SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-001600
Filing Date
2014-10-07
Accepted
2014-10-07 11:02:18
Documents
8
Period of Report
2014-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aptose6k.htm 6-K 11513
2 MATERIAL CHANGE REPORT ex991.htm EX-99.1 14502
3 CERTIFICATE OF AMENDMENT ex992.htm EX-99.2 2306
4 GRAPHIC image_001.jpg GRAPHIC 4888
5 FIRST SUPPLEMENTAL WARRANT INDENTURE ex993.htm EX-99.3 73671
6 GRAPHIC image_002.jpg GRAPHIC 129215
7 GRAPHIC image_003.jpg GRAPHIC 144677
8 GRAPHIC image_004.jpg GRAPHIC 122133
  Complete submission text file 0001279569-14-001600.txt   656244
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7 416-798-1200
Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.) (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 141144679
SIC: 2836 Biological Products, (No Diagnostic Substances)